UBS O'Connor’s Zai Lab ZLAB Stock Holding History

UBS O'Connor’s Portfolio ZLAB Stock Details ZLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15,700	Closed	-$537K	–	347
2022 Q3	$537K	Buy	+15,700	New	+$672K	0.01%	808

Other funds holding ZLAB

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS O'Connor's ZLAB Position: Q4 2022 in Review

UBS O'Connor sold out of Zai Lab (ZLAB) in Q4 2022, closing a stake of 15,700 shares — an estimated $537K sold.

UBS O'Connor first reported a position in ZLAB in Q3 2022 and held it in 1 quarter. The position peaked at $537K in Q3 2022. 166 funds tracked by Wall St. Rank hold ZLAB as of Q4 2022.

UBS O'Connor reported no remaining Zai Lab position as of Q4 2022 after selling out during the quarter.
UBS O'Connor sold 15,700 Zai Lab shares in Q4 2022, an estimated $537K.
UBS O'Connor first reported a position in Zai Lab in Q3 2022 and held it in 1 quarter.
UBS O'Connor's Zai Lab position peaked at $537K in Q3 2022.
166 funds tracked by Wall St. Rank held Zai Lab as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.